|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘 | Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari | 2013 | Gut2013，，11： | 2 |
| 2 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘 | Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari | 2013 | Gut2013，，11： | 2 |
| 3 | Percutaneous transluminal angioplasty balloons for endoscopic ultrasound-guided pancreatic duct interventions显示文摘BACKGROUND Endoscopic ultrasound(EUS)-guided main pancreatic duct(PD)access may be used when conventional endoscopic retrograde cholangiopancreatography(ERCP)techniques fail.The use of a percutaneous transluminal angioplasty balloon(PTAB),originally developed for vascular interventions,can be used to facilitate transmural(e.g.,transgastric)PD access and to dilate high-grade pancreatic strictures.AIM To describe the technique,efficacy,and safety of PTABs for EUS-guided PD interventions.METHODS Patients who underwent EUS with use of a PTAB from March 2011 to August 2021 were retrospectively identified from a tertiary care medical center supply database.PTABs included 3-4 French angioplasty catheters with 3-4 mm balloons designed to use over a 0.018-inch guidewire.The primary outcome was technical success.Secondary outcomes included incidence of adverse events(AEs)and need for early reintervention.RESULTS A total of 23 patients were identified(48%female,mean age 55.8 years).Chronic pancreatitis was the underlying etiology in 13(56.5%)patients,surgically altered anatomy(SAA)with stricture in 7(30.4%),and SAA with post-operative leak in 3(13.0%).Technical success was achieved in 20(87%)cases.Overall AE rate was 26%(n=6).All AEs were mild and included 1 pancreatic duct leak,2 cases of post-procedure pancreatitis,and 3 admissions for post-procedural pain.No patients required early re-intervention.CONCLUSION EUS-guided use of PTABs for PD access and/or stricture management is feasible with an acceptable safety profile and can be considered in patients when conventional ERCP cannulation fails. | Jad P AbiMansour Barham K Abu Dayyeh Michael J Levy Andrew C Storm John A Martin Bret T Petersen Ryan J Law Mark D Topazian Vinay Chandrasekhara | 2022 | World Journal of Gastrointestinal Endoscopy2022，14，8： | 2 |
| 4 | End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients显示文摘AIM To determine if end-stage renal disease (ESRD) is a risk factor for post endoscopic retrograde cholangio-pancreatography (ERCP) adverse events (AEs). METHODS We performed a retrospective cohort study using the Nationwide Inpatient Sample (NIS) 2011-2013. We identified adult patients who underwent ERCP using the International Classification of Diseases 9^(th) Revision (ICD-9-CM). Included patients were divided into three groups: ESRD, chronic kidney disease (CKD), and control. The primary outcome was post-ERCP AEs including pancreatitis, bleeding, and perforation determined based on specific ICD-9-CM codes. Secondary outcomes were length of hospital stay, in-hospital mortality, and admission cost. AEs and mortality were compared using multivariate logistic regression analysis.RESULTS There were 492175 discharges that underwent ERCP during the 3 years. The ESRD and CKD groups contained 7347 and 39403 hospitalizations respectively, whereas the control group had 445424 hospitalizations. Post-ERCP pancreatitis (PEP) was significantly higher in the ESRD group (8.3%) compared to the control group (4.6%) with adjusted odd ratio (aOR) = 1.7 (95% CI: 1.4-2.1, ~aP < 0.001). ESRD was associated with significantly higher ERCP-related bleeding (5.1%) compared to the control group 1.5% (aOR = 1.86, 95%CI: 1.4-2.4, ~aP < 0.001). ESRD had increased hospital mortality 7.1% vs 1.15% in the control OR = 6.6 (95%CI: 5.3-8.2, ~aP < 0.001), longer hospital stay with adjusted mean difference (aMD) = 5.9 d (95% CI: 5.0-6.7 d, ~aP < 0.001) and higher hospitalization charges aMD = $+82064 (95%CI: $68221-$95906, ~aP < 0.001). CONCLUSION ESRD is a risk factor for post-ERCP AEs and is associated with higher hospital mortality. Careful selection and close monitoring is warranted to improve outcomes. | Tarek Sawas Fateh Bazerbachi Samir Haffar Won K Cho Michael J Levy John A Martin Bret T Petersen Mark D Topazian Vinay Chandrasekhara Barham K Abu Dayyeh | 2018 | World Journal of Gastroenterology2018，24，41： | 2 |
| 5 | Optimal guaranteed cost control and filtering for uncertain linear systems显示文摘 | Petersen I R Mcfarlane D C | 1994 | IEEE Trans Automat Control1994，39，9： | 1 |
| 6 | Modeling aerobic car- bon source degradation processes using titrimetric data and com- bined rcspircmetric-titfimetric data: structural and practical iden- tifiability 显示文摘 | Gemaey K Petersen B Dochain D | 2002 | Biotechnology and Bioengineering2002，79，： | 1 |
| 7 | Discursive biases of the environmental research framework DPSIR显示文摘 | Svarstad H Petersen L K Rothman D | | 0，，01： | 1 |
| 8 | Discursive biases of the environmental research framework DPSIR 显示文摘 | SVARSTAD H PETERSEN L K ROTHMAN D | 2008 | Land Use Policy2008，25，1： | 1 |
| 9 | 显示文摘 | Ansbak T Petersen D H Hansen O | 2009 | Microelectron Eng2009，86，： | 1 |
| 10 | NAT for HBV and anti- HBe testing increase blood safety 显示文摘 | Roth WK Weber M Petersen D | 2002 | Transfusion2002，42，7： | 1 |
| 11 | Vascular disease burden and in- hospital outcomes among patients undergoing percutaneous coronary intervention in New York State 显示文摘 | Berger J Petersen J Brown D | 2009 | Cire Cadiovas Interv2009，2，4： | 1 |
| 12 | Discursive biases of the environmental research framework DPSIR 显示文摘 | Svarstad H Petersen L K Rothman D | 2008 | Land Use Policy2008，25，1： | 1 |
| 13 | Health related quality of life in a nationally representative sample of haema- tological patients显示文摘 | JOHNSEN A T THOLSTRUP D PETERSEN M A | 2009 | Eur J Haematol2009，83，1： | 1 |
| 14 | Optimal guaranteed cost filtering for uncertain discrete-time linear systems显示文摘 | McFarlane D C | 1994 | IEEE Trans on Autom Contr1994，39，9： | 1 |
| 15 | Impaired mitochondreial activ- ity in the insulin-resistant offspring of patients with type 2 diabetes 显示文摘 | Petersen KF Dufour S Befroy D | 2004 | N Engl J Med2004，350，： | 1 |
| 16 | Mecha- nisms of Insulin Resistance in Humans and Possible Links With Inflammation显示文摘 | SAVAGE D B PETERSEN K F SHULMAN G I | 2005 | Hypertension2005，45，3： | 1 |
| 17 | Estimating crop yields and production by integrating the FAO crop specific water balance model with real-time satellite data and ground-based ancillary data显示文摘 | Reynolds C A Yitayew M Slack D C Hutchinson C F Huete A Petersen M S | | 0，，： | 1 |
| 18 | Cross-correlations between volume change and price change 显示文摘 | Podobnik B Horvatic D Petersen A M | 2009 | Proceed- ings of the National Academy of Sciences2009，106，22： | 1 |
| 19 | Evaluation of sequential releases of Spalangia endius (Hymenoptera: Pteromalidae) for control of house flies and stable flies (Diptera: Muscidae) associated with confined livestock in eastern Nebraska显示文摘 | Petersen J J Meyer J A Stage D A | 1983 | Journal of Economic Entomology1983，76，2： | 1 |
| 20 | Rapid precipitation oflowvapor pressure solids fromsupercritical fluid solutions:theformation of thin fil ms and powders显示文摘 | Petersen R C Matson D W Smith R D | 1986 | Journal of ChemistrySociety1986，108，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员